Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AHCO NASDAQ:AMED NYSE:CHE NASDAQ:OPCH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAHCOAdaptHealth$10.47-3.8%$10.25$8.51▼$13.43$1.42B1.451.35 million shs1.02 million shsAMEDAmedisys$101.01+0.0%$99.72$92.44▼$101.02$3.32B0.89509,062 shs1.06 million shsCHEChemed$501.75-0.4%$455.54$365.20▼$517.74$6.66B0.52224,350 shs110,806 shsOPCHOption Care Health$21.08-0.3%$21.25$18.01▼$36.80$3.31B0.652.52 million shs1.90 million shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAHCOAdaptHealth-2.94%+2.74%+12.63%-14.53%+14.77%AMEDAmedisys0.00%0.00%0.00%0.00%+3.10%CHEChemed+0.18%+2.43%+15.69%+31.70%+11.23%OPCHOption Care Health-2.40%-4.26%-0.70%-25.89%-28.98%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAHCOAdaptHealth$10.47-3.8%$10.25$8.51▼$13.43$1.42B1.451.35 million shs1.02 million shsAMEDAmedisys$101.01+0.0%$99.72$92.44▼$101.02$3.32B0.89509,062 shs1.06 million shsCHEChemed$501.75-0.4%$455.54$365.20▼$517.74$6.66B0.52224,350 shs110,806 shsOPCHOption Care Health$21.08-0.3%$21.25$18.01▼$36.80$3.31B0.652.52 million shs1.90 million shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAHCOAdaptHealth-2.94%+2.74%+12.63%-14.53%+14.77%AMEDAmedisys0.00%0.00%0.00%0.00%+3.10%CHEChemed+0.18%+2.43%+15.69%+31.70%+11.23%OPCHOption Care Health-2.40%-4.26%-0.70%-25.89%-28.98%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAHCOAdaptHealth 2.67Moderate Buy$14.1435.08% UpsideAMEDAmedisys 0.00N/AN/AN/ACHEChemed 2.17Hold$480.25-4.28% DownsideOPCHOption Care Health 2.57Moderate Buy$30.0842.68% UpsideCurrent Analyst Ratings BreakdownLatest CHE, AMED, OPCH, and AHCO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/21/2026AHCOAdaptHealth Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$11.00 ➝ $13.007/17/2026CHEChemed Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold (C-) ➝ Hold (C)7/17/2026OPCHOption Care Health StephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight ➝ Equal Weight$30.00 ➝ $24.007/17/2026OPCHOption Care Health StephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeOverweight ➝ Equal Weight$24.007/9/2026CHEChemed Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$450.00 ➝ $510.007/6/2026AHCOAdaptHealth Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$18.00 ➝ $15.007/6/2026OPCHOption Care Health Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold6/16/2026OPCHOption Care Health UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy6/8/2026OPCHOption Care Health The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy ➝ Neutral$22.006/8/2026OPCHOption Care Health The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageNeutral$22.005/22/2026AHCOAdaptHealth Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)(Data available from 7/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAHCOAdaptHealth$3.24B0.44$3.91 per share2.68$11.27 per share0.93AMEDAmedisys$2.40B1.38$6.24 per share16.20$38.77 per share2.61CHEChemed$2.53B2.63$24.55 per share20.44$69.15 per share7.26OPCHOption Care Health$5.65B0.59$1.99 per share10.61$8.36 per share2.52Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAHCOAdaptHealth-$70.79M-$0.62N/A9.880.57-2.42%2.76%0.99%8/4/2026 (Estimated)AMEDAmedisys$43.23M$2.5739.3020.871.343.56%12.91%7.29%N/ACHEChemed$265.24M$18.3527.3419.471.8610.23%27.18%17.38%7/28/2026 (Estimated)OPCHOption Care Health$207.59M$1.2916.3411.461.203.64%18.17%7.16%7/29/2026 (Estimated)Latest CHE, AMED, OPCH, and AHCO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2026Q2 2026AHCOAdaptHealth$0.1688N/AN/AN/A$846.77 millionN/A7/29/2026Q2 2026OPCHOption Care Health$0.42N/AN/AN/A$1.42 billionN/A7/28/2026Q2 2026CHEChemed$5.55N/AN/AN/A$665.04 millionN/A4/30/2026Q1 2026OPCHOption Care Health$0.37$0.40+$0.03$0.29$1.39 billion$1.35 billion4/23/2026Q1 2026CHEChemed$5.30$5.65+$0.35$4.84$659.22 million$657.51 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAHCOAdaptHealthN/AN/AN/AN/AN/AAMEDAmedisysN/AN/AN/AN/AN/ACHEChemed$2.400.48%+10.76%13.08%16 YearsOPCHOption Care HealthN/AN/AN/AN/AN/ALatest CHE, AMED, OPCH, and AHCO DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/18/2026CHEChemedquarterly$0.600.55%5/28/20265/28/20266/16/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAHCOAdaptHealth1.210.920.71AMEDAmedisys0.261.361.36CHEChemed0.110.850.83OPCHOption Care Health0.851.641.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAHCOAdaptHealth82.67%AMEDAmedisys94.36%CHEChemed95.85%OPCHOption Care Health98.05%Insider OwnershipCompanyInsider OwnershipAHCOAdaptHealth1.95%AMEDAmedisys2.10%CHEChemed3.33%OPCHOption Care Health1.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAHCOAdaptHealth10,900135.91 million133.27 millionOptionableAMEDAmedisys20,00032.89 million32.20 millionOptionableCHEChemed15,81113.27 million12.83 millionOptionableOPCHOption Care Health8,266157.03 million154.36 millionOptionableCHE, AMED, OPCH, and AHCO HeadlinesRecent News About These CompaniesOption Care Health (OPCH) Expected to Announce Quarterly Earnings on WednesdayJuly 22 at 6:25 AM | marketbeat.comFifth Third Bancorp Grows Holdings in Option Care Health, Inc. $OPCHJuly 22 at 3:35 AM | marketbeat.comOption Care Health, Inc. (NASDAQ:OPCH) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJuly 22 at 2:14 AM | americanbankingnews.comOption Care Health, Inc. (NASDAQ:OPCH) Receives Average Rating of "Moderate Buy" from AnalystsJuly 22 at 2:13 AM | marketbeat.comOption Care Health, Inc. $OPCH Shares Acquired by Jennison Associates LLCJuly 21 at 5:12 AM | marketbeat.comMultiple Headwinds Hurt Option Care Health (OPCH)July 20 at 9:51 AM | insidermonkey.com1,587,636 Shares in Option Care Health, Inc. $OPCH Acquired by Van Berkom & Associates Inc.July 20 at 6:24 AM | marketbeat.comOption Care Health (NASDAQ:OPCH) Cut to Equal Weight at StephensJuly 20 at 1:31 AM | americanbankingnews.comOption Care Health (NASDAQ:OPCH) Lowered to "Hold" Rating by StephensJuly 18, 2026 | marketbeat.comY Intercept Hong Kong Ltd Sells 70,673 Shares of Option Care Health, Inc. $OPCHJuly 14, 2026 | marketbeat.com2,610,947 Shares in Option Care Health, Inc. $OPCH Bought by Sumitomo Mitsui Trust Group Inc.July 12, 2026 | marketbeat.comKornitzer Capital Management Inc. KS Reduces Stock Holdings in Option Care Health, Inc. $OPCHJuly 11, 2026 | marketbeat.comOption Care Health to Announce Second Quarter 2026 Financial Results and Host Conference CallJuly 9, 2026 | globenewswire.comOption Care Health (NASDAQ:OPCH) Raised to "Hold" at Zacks ResearchJuly 8, 2026 | marketbeat.comWhy Option Care Health’s (OPCH) Alternate-Site Infusion Model Fits the Site-of-Care ShiftJuly 7, 2026 | insidermonkey.comOption Care Health: Mildly Interesting After PullbackJuly 5, 2026 | seekingalpha.comLouisiana State Employees Retirement System Acquires Shares of 46,000 Option Care Health, Inc. $OPCHJuly 4, 2026 | marketbeat.com192,894 Shares in Option Care Health, Inc. $OPCH Purchased by Fideuram Intesa Sanpaolo Private Banking S.P.A.July 4, 2026 | marketbeat.comCorient Private Wealth LLC Has $953,000 Stock Position in Option Care Health, Inc. $OPCHJuly 3, 2026 | marketbeat.com1 stock under $50 to consider right now and 2 we find riskyJune 30, 2026 | msn.comOption Care Health, Inc. (NASDAQ:OPCH) Given Consensus Recommendation of "Moderate Buy" by AnalystsJune 27, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesAirJoule Unveils Prime System, Clearing Path to CommercializationBy Thomas Hughes | July 1, 2026Microsoft Solves AI’s Biggest Bottleneck With Chevron DealBy Chris Markoch | June 25, 2026Chevron’s Microsoft Deal Turns Natural Gas Into an AI TradeBy Jeffrey Neal Johnson | June 24, 2026Rocket Lab's NASA Win Tests Key Support After Sharp PullbackBy Ryan Hasson | June 26, 2026Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity YetBy Thomas Hughes | July 14, 2026CHE, AMED, OPCH, and AHCO Company DescriptionsAdaptHealth NASDAQ:AHCO$10.47 -0.41 (-3.77%) Closing price 04:00 PM EasternExtended Trading$10.60 +0.13 (+1.28%) As of 04:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.Amedisys NASDAQ:AMEDAmedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.Chemed NYSE:CHE$501.75 -1.77 (-0.35%) Closing price 03:59 PM EasternExtended Trading$502.58 +0.83 (+0.17%) As of 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Option Care Health NASDAQ:OPCH$21.08 -0.07 (-0.33%) Closing price 04:00 PM EasternExtended Trading$21.15 +0.07 (+0.33%) As of 06:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD’s $5 Billion Anthropic Deal Could Redraw the AI Chip Battle Alphabet Crushed Earnings, But One Number Spooked the Market Premium Retail’s Stress Test Is Separating Winners From Losers GE Vernova Just Sent a Mixed AI Signal to Investors Otis Took Another Guidance Cut—But the Story Isn't Over Philip Morris Trimmed Guidance, But Its Growth Story Looks Unshaken The 2026 Blueprint: 6 Stocks for a Brand New Portfolio Cementing the Sky: Why NVIDIA’s Bet on Nebius Matters Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
